Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2021-06-30 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东减持计划期限届满的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the expiration of a share reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the methods, dates, and compliance with relevant regulations. There is no financial report or earnings data presented, only disclosure of shareholding changes by a major shareholder. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2021-06-30 Chinese
关于持股5%以上股东持股比例变动达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the reduction in shareholding by Longwood Biotechnologies Inc. by 1%, including dates, share counts, and compliance with regulations. This matches the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds. The document length is short and focused solely on shareholding changes, not a full financial report or other types of filings.
2021-06-30 Chinese
关于控股股东、实际控制人的一致行动人股份减持计划数量过半的进展公告
Transaction in Own Shares Classification · 95% confidence The document is titled '减持进展公告' which translates to 'Announcement of Progress on Share Reduction'. It details the progress of a planned share reduction by a major shareholder, including specific dates, quantities, and compliance with regulatory requirements. The content focuses on the update of a shareholding reduction plan, not on financial results, management changes, or other report types. The document length is 1878 characters, which is relatively short and typical for a progress announcement. This fits the category of Transaction in Own Shares (POS), which covers reports of the company or its major shareholders buying back or selling shares. Therefore, the document is best classified as POS.
2021-06-01 Chinese
关于募集资金使用完毕并注销募集资金专户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the use of raised funds and the cancellation of the special account for those funds. It details the original fundraising, the management of the funds, the projects funded, and the decision to permanently supplement working capital with remaining funds. It references regulatory guidelines and approvals but does not contain financial statements or detailed financial performance data. The document length is short (1854 characters) and it is clearly an announcement about the status and use of fundraising proceeds, not a full financial report or audit. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2021-05-28 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled '2020 年年度权益分派实施公告' which translates to '2020 Annual Equity Distribution Implementation Announcement'. It details the company's dividend distribution plan for the 2020 fiscal year, including the dividend amount per share, the record date, ex-dividend date, and the method of dividend payment. It also references the approval of the dividend plan at the 2020 Annual General Meeting and provides contact information for inquiries. The document is relatively short (1704 characters) and focuses solely on the announcement of the dividend distribution implementation, not the full annual report or financial statements. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2021-05-13 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is titled as an announcement regarding the appointment of senior management personnel. It details the names, qualifications, and backgrounds of newly appointed executives such as the general manager, deputy general managers, financial officer, and board secretary. There is no financial data, earnings information, or regulatory filings related to financial performance. The content focuses solely on management changes and appointments. The document length is 3019 characters, which is relatively short and consistent with a management announcement rather than a full report. Therefore, the document fits the category of Board/Management Information (MANG).
2021-04-30 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.